Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |